Abbott Laboratories (ABT) Minority Interest (2009 - 2026)

Abbott Laboratories has disclosed Minority Interest across 18 years of filings, most recently posting $640.0 million for Q1 2026.

• Minority Interest for Q1 2026 came in at $640.0 million, up 152.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $640.0 million (up 152.96% YoY), and the FY2025 annual result was $641.0 million, up 170.46% from the prior year.
• Minority Interest came in at $640.0 million for Q1 2026 at Abbott Laboratories, roughly flat from $641.0 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $641.0 million in Q4 2025 to a low of $209.0 million in Q3 2022.
• The 5-year median for Minority Interest is $232.0 million (2024), against an average of $283.8 million.
• Across the five-year window, Minority Interest decreased 3.48% in 2023 and jumped 170.46% in 2025, its largest moves.
• Abbott Laboratories' Minority Interest stood at $219.0 million in 2022, then increased by 2.28% to $224.0 million in 2023, then climbed by 5.8% to $237.0 million in 2024, then surged by 170.46% to $641.0 million in 2025, then dropped by 0.16% to $640.0 million in 2026.
• The last three Minority Interest figures came in at $640.0 million (Q1 2026), $641.0 million (Q4 2025), and $310.0 million (Q3 2025), per Business Quant data.